Search for: "Watson Laboratories Inc."
Results 81 - 100
of 133
Sort by Relevance
|
Sort by Date
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
12 Dec 2010, 9:47 pm
Hunt • Defendants: IMPAX Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc. [read post]
10 Dec 2010, 2:31 pm
Watson Laboratories, Inc., C.A. [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
14 Nov 2010, 8:48 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-01969; filed November 11, 2010 in the District Court of Nevada • Plaintiffs: Astrazeneca UK Ltd.; IPR Pharmaceuticals, Inc.; Shionogi Seiyaku Kabushiki Kaisha • Defendants: Watson Pharmaceuticals, Inc.; Watson Pharma, Inc.; Watson Laboratories, Inc. [read post]
12 Oct 2010, 8:56 pm
(FDA Law Blog) Lyrica (Pregabalin) – US: Pfizer files patent infringement suit against Lupin in response to Para IV certification filing (Patent Docs) Opana (Oxymorphone) – US: Watson reaches settlement with Endo over Opana ER (SmartBrief) OsmoPrep (Sodium biphosphate, Sodium phosphate) – US: Salix Pharma and Novel Labs settle OsmoPrep patent litigation (Patent Docs) Sanctura XR (Trospium) – US: Allergan file patent infringement complaints against Paddock… [read post]
27 Sep 2010, 12:59 am
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
23 Sep 2010, 12:39 pm
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
5 Aug 2010, 2:08 pm
Wyeth Laboratories, Inc., 533 N.E.2d 748 (Ohio 1988) (the Ohio Supreme Court rejecting the theory). [read post]
28 Jul 2010, 12:06 am
Watson Laboratories, Inc. [read post]
8 Jun 2010, 8:14 am
Watson Laboratories, Inc., No. 1:2010cv01323 (filed May 24, 2010); this Hatch-Waxman patent infringement lawsuit was brought by Genzyme after Watson sought Food and Drug Administration (FDA) approval to market in the US a generic version of the company's Renvela(R) drug product (sevelamer carbonate). [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
20 May 2010, 9:55 pm
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
13 May 2010, 4:58 pm
Barr Laboratories, Inc. [read post]
9 May 2010, 9:58 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-00647; filed May 5, 2010 in the District Court of Nevada • Plaintiff: Eli Lilly & Company • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
6 May 2010, 4:12 pm
Abbott Laboratories, 397 F. [read post]
5 May 2010, 4:46 am
Watson Laboratories, Inc. [read post]
2 May 2010, 9:52 pm
-Florida; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
